Pacira BioSciences Inc (PCRX)
25.90
-0.91
(-3.39%)
USD |
NASDAQ |
Apr 24, 16:00
25.91
+0.01
(+0.04%)
After-Hours: 20:00
Pacira BioSciences Cash and Short Term Investments (Quarterly): 278.58M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 278.58M |
| September 30, 2023 | 235.19M |
| June 30, 2023 | 220.77M |
| March 31, 2023 | 174.00M |
| December 31, 2022 | 288.65M |
| September 30, 2022 | 328.72M |
| June 30, 2022 | 316.39M |
| March 31, 2022 | 452.19M |
| December 31, 2021 | 656.41M |
| September 30, 2021 | 693.86M |
| June 30, 2021 | 646.60M |
| March 31, 2021 | 590.06M |
| December 31, 2020 | 521.66M |
| September 30, 2020 | 532.12M |
| June 30, 2020 | 326.79M |
| March 31, 2020 | 318.46M |
| December 31, 2019 | 291.95M |
| September 30, 2019 | 265.64M |
| June 30, 2019 | 292.24M |
| March 31, 2019 | 412.44M |
| December 31, 2018 | 383.45M |
| September 30, 2018 | 386.41M |
| June 30, 2018 | 371.32M |
| March 31, 2018 | 339.79M |
| December 31, 2017 | 311.35M |
| Date | Value |
|---|---|
| September 30, 2017 | 294.08M |
| June 30, 2017 | 382.44M |
| March 31, 2017 | 383.70M |
| December 31, 2016 | 172.60M |
| September 30, 2016 | 161.13M |
| June 30, 2016 | 162.67M |
| March 31, 2016 | 150.02M |
| December 31, 2015 | 158.96M |
| September 30, 2015 | 146.44M |
| June 30, 2015 | 153.15M |
| March 31, 2015 | 154.89M |
| December 31, 2014 | 156.66M |
| September 30, 2014 | 149.73M |
| June 30, 2014 | 163.86M |
| March 31, 2014 | 64.57M |
| December 31, 2013 | 72.15M |
| September 30, 2013 | 81.85M |
| June 30, 2013 | 95.96M |
| March 31, 2013 | 110.25M |
| December 31, 2012 | 41.05M |
| September 30, 2012 | 66.95M |
| June 30, 2012 | 84.28M |
| March 31, 2012 | 54.83M |
| December 31, 2011 | 76.15M |
| September 30, 2011 | 37.07M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
174.00M
Minimum
Mar 2023
693.86M
Maximum
Sep 2021
391.07M
Average
318.46M
Median
Mar 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| Dynavax Technologies Corp | 742.30M |
| Arbutus Biopharma Corp | 126.00M |
| Chimerix Inc | 182.84M |
| Karyopharm Therapeutics Inc | 191.44M |
| FibroGen Inc | 235.59M |